Learn how you can manage and alleviate your current side effects while actively working to prevent a relapse or secondary cancer using evidence-based, non-toxic therapies.
Click the orange button to the right to learn more.
“A clear and unambiguous relation exists between therapeutic exposures and specific adverse events experienced by the survivors…”
Why is the study linked below only studying surviving your cancer compared to your heart health? I understand that chemotherapy-induced heart damage is a serious long-term problem for cancer survivors. But what about all the other documented long-term and late stage side effects of aggressive toxicity such as:
My guess is that the study was examining cancer versus death caused by cancer therapy. However, a treatment-related cancer certainly kills. While cancer survivors may not die specifically from their nerve damage (CIPN, RILN, etc.) they can die from spending decades in a wheelchair. And any Multiple Myeloma survivor can tell you that you can die from health issues sustained from weakened bones after a fall.
The point of this post is not to rail on conventional oncologic therapies. The point of this post is to highlight the serious damage done by chemotherapy and radiation and then discuss evidence-based, non-toxic healing therapies.
The list of side effects below is my combination of cancer survival since my active treatment in ’94, ’95 ,’96, Each blog post lists those therapies that I have researched along with my personal experience.
If you’ve reached remission from your cancer, great. My experience is that the cancer survivor in remission must then focus on managing short, long-term and late stage side effects. Check-ups interspersed with nutrition, exercise, detoxification, maybe some Acupuncture, sauna, more exercise, etc. etc.
Are you a cancer survivor? Scroll down the page post a comment or question and I will get back to you ASAP.
New cancer diagnosis appeared associated with increased risk for cardiovascular death, as well as incident heart failure, stroke or pulmonary embolism, according to a retrospective cohort study published in JACC: CardioOncology.
“This risk persisted to at least 7 years from cancer diagnosis and appeared most pronounced in patients with hematologic, gastrointestinal, genitourinary and thoracic malignancies,”
Paterson and colleagues pursued the research because, despite the knowledge that patients with cancer and cancer survivors are at increased risk for heart failure, previous data conflicted regarding long-term risk for other cardiovascular events, as well as risk according to cancer site.
“Population studies to date have largely evaluated the risk [for] cardiovascular disease — and usually only heart failure — in patients with breast cancer,” Paterson said. “We performed a comprehensive analysis of the risk [for] incident cardiovascular disease in patients with a new cancer diagnosis of any type.”
Paterson and colleagues used time-to-event survival models, after adjusting for comorbidities and sociodemographic factors, to compare the two cohorts with respect to risk for subsequent cardiovascular events, which included
Determining the impact of new cancer diagnosis on risk for fatal and nonfatal cardiovascular events served as the primary outcome…
The analysis included 4,519,243 adults who resided in Alberta, Canada, from April 2007 to December 2018.
At median follow-up of 11.8 years, results showed 73,360 cardiovascular deaths and 470,481 nonfatal cardiovascular events. After adjustment, researchers reported participants with cancer demonstrated the following HRs compared with participants without cancer:
“More than 12 000 children and adolescents are diagnosed with cancer each year in the United States.1Advancements in therapeutic and supportive care strategies have resulted in significant improvements in survival; the overall 5-year survival rate is approaching 80%.1 However, two-thirds of these survivors experience at least one chronic health condition,2 resulting in considerable morbidity and premature mortality among childhood cancer survivors.3 A clear and unambiguous relation exists between therapeutic exposures and specific adverse events experienced by the survivors…